GGrantIndex
← Search

TARGETING 3BETA-HSD1 PHOSPHORYLATION TO REVERSE PROSTATE CANCER HORMONE THERAPY RESISTANCE

$293,514FY2020Department of the ArmyDOD

The Cleveland Clinic Foundation

Investigators

View source on USAspending →
TARGETING 3BETA-HSD1 PHOSPHORYLATION TO REVERSE PROSTATE CANCER HORMONE THERAPY RESISTANCE · GrantIndex